Geisinger Health System
SARS-CoV-2 Pandemic A Test Case for Role of Lab Data in Population Health
A number of labs and informatics firms are using test data to help guide the response to the virus in a spirit similar to that of initiatives like Lab 2.0.
The firm looks to win new customers among US providers while also partnering with IVD companies to embed its lab data analysis tools in their instruments.
Smartphone-Based Kidney Disease Test 510(k) Cleared, Healthy.io Raises $60M
The firm said the clearance authorizes use of its smartphone-based albumin-to-creatinine ratio test by healthcare professionals at the point of care.
Geisinger Teams With Medial EarlySign for AI-based Flagging of High-Risk Patients
Israel-based software company Medial EarlySign will work with Geisinger's innovation center to develop technologies to predict lower GI and other "high-burden" diseases.
The firm has developed a digital platform that determines whether patients meet guidelines for genetic testing, and if so, what test they should receive.